Effect of BIBW 2948 BS in COPD

PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

January 17, 2007

Primary Completion Date

July 9, 2008

Study Completion Date

July 9, 2008

Conditions
Pulmonary Disease, Chronic ObstructiveBronchitis, Chronic
Interventions
DRUG

BIBW 2948 BS

Capsule

DRUG

Placebo

Capsule

Trial Locations (6)

Unknown

1219.5.03 Boehringer Ingelheim Investigational Site, Birmingham

1219.5.01 Boehringer Ingelheim Investigational Site, San Francisco

1219.5.02 Boehringer Ingelheim Investigational Site, Denver

1219.5.04 Boehringer Ingelheim Investigational Site, Philadelphia

1219.5.06 Boehringer Ingelheim Investigational Site, Freiburg/Breisgau

1219.5.05 Boehringer Ingelheim Investigational Site, Hanover

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY